Flagship Pioneering’s Moderna MRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$128M	Hold	4,632,149	–	–	47.6%	1
2025 Q1	$131M	Hold	4,632,149	–	–	55.7%	1
2024 Q4	$193M	Hold	4,632,149	–	–	57.63%	1
2024 Q3	$310M	Hold	4,632,149	–	–	52.3%	1
2024 Q2	$550M	Sell	4,632,149 -5,033,889	-52%	-$598M	65.22%	1
2024 Q1	$1.03B	Hold	9,666,038	–	–	67.56%	1
2023 Q4	$961M	Hold	9,666,038	–	–	72.53%	1
2023 Q3	$998M	Sell	9,666,038 -3,220,705	-25%	-$333M	72.47%	1
2023 Q2	$1.57B	Hold	12,886,743	–	–	69.88%	1
2023 Q1	$1.98B	Hold	12,886,743	–	–	76.91%	1
2022 Q4	$2.31B	Hold	12,886,743	–	–	73.9%	1
2022 Q3	$1.52B	Hold	12,886,743	–	–	64.14%	1
2022 Q2	$1.84B	Sell	12,886,743 -4,694,273	-27%	-$671M	69.35%	1
2022 Q1	$3.03B	Hold	17,581,016	–	–	71.11%	1
2021 Q4	$4.47B	Hold	17,581,016	–	–	69.04%	1
2021 Q3	$6.77B	Sell	17,581,016 -3,000,000	-15%	-$1.15B	70.86%	1
2021 Q2	$4.84B	Hold	20,581,016	–	–	61.77%	1
2021 Q1	$2.7B	Sell	20,581,016 -10,290,508	-33%	-$1.35B	43.16%	1
2020 Q4	$3.23B	Hold	30,871,524	–	–	58.71%	1
2020 Q3	$2.18B	Sell	30,871,524 -9,000,000	-23%	-$637M	60.34%	1
2020 Q2	$2.56B	Sell	39,871,524 -11,000,000	-22%	-$706M	74.39%	1
2020 Q1	$1.52B	Hold	50,871,524	–	–	71.42%	1
2019 Q4	$995M	Sell	50,871,524 -7,935,855	-13%	-$155M	55.62%	1
2019 Q3	$936M	Hold	58,807,379	–	–	51.21%	1
2019 Q2	$861M	Hold	58,807,379	–	–	37.27%	1
2019 Q1	$1.2B	Hold	58,807,379	–	–	45.29%	1
2018 Q4	$898M	Buy	+58,807,379	New	+$898M	43.86%	1